3.17000 USD
0.08
2.46%
Last update Dec 15, 3:59 PM EST
Pre-market
Day range
3.16000
3.38500
Previous close
3.25
Open
3.25
Access this stock data via API
Subscribe
Aclaris Therapeutics Inc.
3.17
0.08
2.46%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.3M 1.8M 1.5M 9.2M
Cost of revenue 2.4M 1.9M 1.5M 9.3M
Gross profit 850K -73K -61K -90K
Operating expense
Research & development 13.0M 11.4M 11.6M 9.0M
Selling general and admin 4.9M 5.4M 6.1M 5.0M
Other operating expenses
Operating income -17.0M -16.9M -17.8M -14.1M
Non operating interest income
Income 1.8M 2.0M 2.2M
Expense
Other income expense 616K -539K 533K -76.6M
Pretax income -14.6M -15.4M -15.1M -96.6M
Tax provision
Net income -14.6M -15.4M -15.1M -96.6M
Basic EPS -0.1 -0.1 -0.1 -1.0
Diluted EPS -0.1 -0.1 -0.1 -1.0
Basic average shares 122.6M 122.6M 122.4M 95.3M
Diluted average shares 122.6M 122.6M 122.4M 95.3M
EBITDA -16.8M -15.3M -17.4M 71.7M
Net income from continuing op. -14.6M -15.4M -15.1M -96.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 3 hours 1 minute

06:28
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).